Concentration Effects on Turnover Rates
An indirect response changes because a drug modifies the rate at which a response is produced or removed. For a protein concentration, for example, a drug may alter synthesis, degradation, or both. The drug’s concentration effect is represented on the relevant rate; the protein concentration then changes over time as production and loss become imbalanced. This distinction matters because a percentage change in a rate does not generally produce the same percentage change in the steady-state response.
The introductory material on the four classical indirect-response model types identifies production and loss as the two rate processes that can be modulated. Here, each affected rate is given a saturable Emax concentration function. The calculations below assume that drug concentration is constant, so each modified rate is constant while the response approaches its new steady state.
The notation \(E_{\max}\) and \(EC_{50}\) is used here for stimulation, and \(I_{\max}\) and \(IC_{50}\) for inhibition. For nonnegative concentration, assume \(E_{\max}\geq 0\), \(EC_{50}>0\), and \(0\leq I_{\max}\leq 1\), with \(IC_{50}>0\). Under these usual constraints, a stimulated rate is nonnegative and an inhibited rate remains nonnegative. In particular, \(I_{\max}=1\) represents complete inhibition only in the limiting case as concentration tends to infinity; at finite concentration the inhibition multiplier remains positive.
The fractional concentration term \(C/(EC_{50}+C)\) is zero at \(C=0\), equals one-half at \(C=EC_{50}\), and approaches one as concentration becomes large. Thus \(E_{\max}\) is the maximum fractional increase above baseline in the specified rate. Similarly, \(I_{\max}\) is the maximum fractional decrease from baseline. These parameters describe rate modulation, not a maximum response concentration.
Steady State Under Rate Modulation
At a fixed concentration, a steady state \(R_{\mathrm{ss}}\) is a value at which the response is no longer changing: \(dR/dt=0\). If the modified loss-rate constant is positive, setting the differential equation to zero gives a unique steady state. With no drug, the baseline steady state is \(R_0=k_{\mathrm{in},0}/k_{\mathrm{out},0}\). Dividing the on-drug steady state by the baseline shows how the two rate multipliers combine.
For example, a twofold increase in production with unchanged loss doubles the steady-state response. A twofold increase in loss with unchanged production halves it. If both rates change, their multipliers form a ratio: a production multiplier of 2 and a loss multiplier of 0.8 give a steady-state multiplier of \(2/0.8=2.5\), not \(2+0.8\). A higher response can therefore result from stimulated production, inhibited loss, or a combination; the steady-state value alone does not identify which rate changed.
The steady state is stable under the stated constant-rate model whenever \(k_{\mathrm{out}}(C)>0\). Subtract the steady-state equation from the differential equation to obtain \(d(R-R_{\mathrm{ss}})/dt=-k_{\mathrm{out}}(C)(R-R_{\mathrm{ss}})\). Solving this first-order equation gives
Because the exponential term tends to zero, the response approaches \(R_{\mathrm{ss}}\). The rate constant \(k_{\mathrm{out}}(C)\), with units of inverse time, determines the approach rate; it does not by itself determine the steady-state magnitude. If the loss-rate constant is zero while production is positive, no finite steady state exists in this model: the response increases at the constant rate \(k_{\mathrm{in}}(C)\).
Worked Example: Inhibiting Production
Suppose a hypothetical protein has baseline production \(k_{\mathrm{in},0}=12\) ng/mL/day and loss-rate constant \(k_{\mathrm{out},0}=0.30\) day\(^{-1}\). A drug inhibits production with \(I_{\max}=0.75\), \(IC_{50}=2\) mg/L, and constant concentration \(C=4\) mg/L. Assume the drug does not affect loss. Find the baseline and on-drug steady states.
The baseline value is \(R_0=12/0.30=40.0\) ng/mL. The production multiplier is $$ 1-I_{\max}\frac{C}{IC_{50}+C} =1-0.75\frac{4}{2+4} =1-0.500=0.500. $$
Therefore \(k_{\mathrm{in}}(C)=12(0.500)=6.00\) ng/mL/day, while \(k_{\mathrm{out}}(C)=0.30\) day\(^{-1}\). The on-drug steady state is $$ R_{\mathrm{ss}}=\frac{6.00\ \text{ng/mL/day}}{0.30\ \text{day}^{-1}} =20.0\ \text{ng/mL}. $$
The response is one-half its baseline value because production is halved and loss is unchanged. This is a steady-state prediction under constant concentration, not a claim that the response changes immediately to 20.0 ng/mL.
Combining Production and Loss Effects
Separate Emax functions can be specified for production and loss when the model assumes that concentration modulates both rates. Each function must use parameters appropriate to its own rate; a production \(EC_{50}\), for instance, need not equal a loss \(IC_{50}\). The rate equations should be written explicitly before calculating the response, so that the direction and magnitude of each effect are unambiguous.
Worked Example: Stimulation of Production and Inhibition of Loss
Consider a hypothetical response with baseline \(R_0=80\) ng/mL and baseline loss-rate constant \(k_{\mathrm{out},0}=0.20\) h\(^{-1}\). Thus baseline production is \(k_{\mathrm{in},0}=80(0.20)=16\) ng/mL/h. At \(C=3\) nM, production is stimulated with \(E_{\max}=2.0\), \(EC_{50}=3\) nM, while loss is inhibited with \(I_{\max}=0.60\), \(IC_{50}=6\) nM. Calculate the new steady state.
For production, the multiplier is $$ 1+2.0\frac{3}{3+3}=1+1.00=2.00, $$ so \(k_{\mathrm{in}}(C)=16(2.00)=32.0\) ng/mL/h. For loss, the multiplier is $$ 1-0.60\frac{3}{6+3}=1-0.200=0.800, $$ so \(k_{\mathrm{out}}(C)=0.20(0.800)=0.160\) h\(^{-1}\).
The resulting steady state is $$ R_{\mathrm{ss}}=\frac{32.0\ \text{ng/mL/h}}{0.160\ \text{h}^{-1}} =200\ \text{ng/mL}. $$
Equivalently, relative to baseline the response multiplier is \(2.00/0.800=2.50\), and \(80(2.50)=200\) ng/mL. The arithmetic shows why the rate effects should be combined as a ratio rather than added.
Worked Example: Stimulation of Loss
A hypothetical protein has baseline production \(k_{\mathrm{in},0}=5.00\) mg/L/day and baseline loss-rate constant \(k_{\mathrm{out},0}=0.100\) day\(^{-1}\), giving \(R_0=50.0\) mg/L. At a constant concentration of \(8\) µM, a drug stimulates loss with \(E_{\max}=1.5\) and \(EC_{50}=4\) µM; production is unaffected. Find the steady state.
The loss multiplier is \(1+1.5(8)/(4+8)=1+1.00=2.00\). Thus \(k_{\mathrm{out}}(C)=0.100(2.00)=0.200\) day\(^{-1}\), while production remains \(5.00\) mg/L/day. Therefore $$ R_{\mathrm{ss}}=\frac{5.00\ \text{mg/L/day}}{0.200\ \text{day}^{-1}} =25.0\ \text{mg/L}. $$
Stimulating loss doubles the loss-rate constant and halves the steady-state response. The steady-state reduction is not itself the Emax parameter: \(E_{\max}=1.5\) specifies a maximum 150% increase in the loss rate, not a 150% reduction in protein concentration.
Assumptions, Diagnostics, and Alternatives
These calculations rely on a particular set of assumptions. The concentration \(C\) is constant, or changes slowly enough that the fixed-concentration calculation is being used only as an approximation. The rate effect is an instantaneous function of concentration, with no delay, hysteresis, or dependence on the response itself. Loss is first-order in \(R\), so its flux is \(k_{\mathrm{out}}(C)R\), and the specified rate constants and Emax parameters are treated as fixed. The equations do not establish that a drug truly acts through the proposed rate; that mechanism needs to be supported by the design and data.
Several checks can reveal a mistaken specification or calculation:
- Check units. \(C\), \(EC_{50}\), and \(IC_{50}\) must use the same concentration units. Production has units of response per time, loss has units of inverse time, and their ratio has response units.
- Check the zero-concentration limit. At \(C=0\), each multiplier is 1 and the steady state returns to \(R_0\).
- Check direction and bounds. Stimulation should not reduce its rate for \(E_{\max}\geq0\); inhibition with \(0\leq I_{\max}\leq1\) should not make its rate negative.
- Check the plateau. At high concentration, the stimulation multiplier approaches \(1+E_{\max}\), and the inhibition multiplier approaches \(1-I_{\max}\). A calculation outside these limiting values signals an arithmetic or parameterization error.
- Check whether a steady state exists. The formula \(k_{\mathrm{in}}/k_{\mathrm{out}}\) requires positive loss. A zero loss rate with positive production produces continued accumulation rather than a finite equilibrium.
An Emax function is saturable, unlike a linear concentration effect. A linear approximation can be useful over a narrow concentration range, but it should not be extrapolated far beyond that range: it can predict indefinitely increasing stimulation or, for inhibition, negative rates. A more flexible sigmoidal concentration function can represent a steeper transition, but it introduces an additional shape parameter and requires data that inform it. Neither choice changes the rate-balance logic for a constant concentration; the modified rates still determine the steady state through their ratio.
When concentration varies materially over time, the constant-concentration steady-state formula does not describe the full response trajectory. Instead, the concentration history must be used in the rate functions and the resulting differential equation solved over time. The response may lag behind concentration because it has its own turnover time. The formula remains useful for interpreting an equilibrium at a specified fixed concentration, but it should not be treated as the instantaneous response during changing exposure.
Common Pitfall
Check Your Understanding
Answer each question, then compare your reasoning with the brief solutions.
- A baseline production rate is 9 mg/L/day and the loss-rate constant is 0.15 day\(^{-1}\). Production is stimulated with \(E_{\max}=1\) and \(EC_{50}=2\) mg/L. At \(C=2\) mg/L, with no effect on loss, what is the steady state?
- For an inhibition function with \(I_{\max}=0.8\), what is the rate multiplier at \(C=IC_{50}\)?
- Production is multiplied by 1.5 and loss by 1.2. What is the multiplier on the steady-state response, relative to baseline?
- Why does a zero loss-rate constant with positive production prevent a finite steady state in this model?
Solutions. (1) Baseline \(R_0=9/0.15=60\) mg/L. The production multiplier is \(1+1(2)/(2+2)=1.5\), so the new steady state is \(60(1.5)=90.0\) mg/L. (2) At \(C=IC_{50}\), the inhibitory multiplier is \(1-I_{\max}/2=1-0.4=0.600\). (3) The response multiplier is \(1.5/1.2=1.25\). (4) With zero loss, \(dR/dt=k_{\mathrm{in}}>0\) at every finite response, so production continues to accumulate and no finite value makes \(dR/dt=0\).